Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report)’s stock price gapped down prior to trading on Thursday. The stock had previously closed at $0.90, but opened at $0.8076. Akso Health Group shares last traded at $0.9390, with a volume of 102,631 shares trading hands.
Analysts Set New Price Targets
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Akso Health Group in a research note on Friday, July 17th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.
Read Our Latest Research Report on AHG
Akso Health Group Trading Up 2.2%
Akso Health Group (NASDAQ:AHG – Get Free Report) last announced its earnings results on Thursday, July 23rd. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $3.42 million during the quarter.
Hedge Funds Weigh In On Akso Health Group
A hedge fund recently bought a new position in Akso Health Group stock. Citadel Advisors LLC bought a new stake in Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 46,026 shares of the company’s stock, valued at approximately $69,000. 1.21% of the stock is currently owned by hedge funds and other institutional investors.
About Akso Health Group
Akso Health Group Limited (NASDAQ: AHG) is a healthcare company focused on providing health management and medical services in China. Its activities include medical examinations, health consultations, and related healthcare management services.
The company also provides clinical healthcare services through its medical operations and may offer healthcare-related products and ancillary services. Its business is primarily oriented toward serving patients and consumers in the Chinese healthcare market.
Akso Health Group is organized as a holding company and conducts its operations through subsidiaries.
Recommended Stories
- Five stocks we like better than Akso Health Group
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
- First Watch’s Growth Story Meets a Reality Check
- Down 50% and Climbing Again: 3 AI Stocks Rebuilding After Brutal Pullbacks
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
